{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:52:31Z","timestamp":1791589951454,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajpc.2026.101574","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:54:50Z","timestamp":1774396490000},"page":"101574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association of systemic inflammation with major adverse cardiovascular events in patients with acute myocardial infarction"],"prefix":"10.1016","volume":"29","author":[{"given":"Chi","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Marieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Skaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Ryali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuba","family":"Popadic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"E\u2024 Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajpc.2026.101574_bib0001","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"7578","key":"10.1016\/j.ajpc.2026.101574_bib0002","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ajpc.2026.101574_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2016.01.021","article-title":"Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction","volume":"175","author":"Pilgrim","year":"2016","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021682","article-title":"Trends in premature mortality from acute myocardial infarction in the United States, 1999 to 2019","volume":"11","author":"Dani","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-017-0482-9","article-title":"Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review","volume":"17","author":"Johansson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"41","key":"10.1016\/j.ajpc.2026.101574_bib0006","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with ST-elevation myocardial infarction during the last 20\u2009years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000172","article-title":"Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in western Australia","volume":"2","author":"Hung","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101574_bib0010","article-title":"Inflammation in cardiovascular disease: a comprehensive review of biomarkers and therapeutic targets","volume":"15","author":"Gupta","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101574_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2023","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101574_bib0012","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/clc.23017","article-title":"C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up","volume":"41","author":"Vanhaverbeke","year":"2018","journal-title":"Clin Cardiol"},{"issue":"17","key":"10.1016\/j.ajpc.2026.101574_bib0013","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101574_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1215802","article-title":"Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers","volume":"2020","author":"Berezin","year":"2020","journal-title":"Dis Markers"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2026.101574_bib0016","article-title":"Prognostic role of high sensitivity c-reactive protein in patients with acute myocardial infarction","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101574_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001869","article-title":"High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI","volume":"8","author":"T\u00f8llefsen","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.ajpc.2026.101574_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am J Prev Cardiol"},{"issue":"13","key":"10.1016\/j.ajpc.2026.101574_bib0019","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity c-reactive protein","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101574_bib0021","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A test in context: high-sensitivity c-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101574_bib0022","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/08820139.2020.1795876","article-title":"Predictive value of blood interleukin-6 level in patients with acute coronary syndrome: a meta-analysis","volume":"50","author":"Li","year":"2021","journal-title":"Immunol Invest"},{"key":"10.1016\/j.ajpc.2026.101574_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2017.09.019","article-title":"High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction","volume":"266","author":"Pokharel","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101574_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0026","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40119-024-00376-3","article-title":"Recent advances in targeted management of inflammation in atherosclerosis: a narrative review","volume":"13","author":"Zubir\u00e1n","year":"2024","journal-title":"Cardiol Ther"},{"issue":"27","key":"10.1016\/j.ajpc.2026.101574_bib0027","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101574_bib0028","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ajpc.2026.101574_bib0029","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ajpc.2026.101574_bib0030","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101574_bib0031","unstructured":"Komodo Health Inc. Healthcare map. 2025."},{"issue":"10289","key":"10.1016\/j.ajpc.2026.101574_bib0032","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101574_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012638","article-title":"HsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study","volume":"8","author":"Carrero","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101574_bib0034","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S1474-4422(25)00306-0","article-title":"High-sensitivity C-reactive protein, LDL cholesterol, lipoprotein(a) and 30-year risk of stroke in healthy women: a prospective, longitudinal cohort study","volume":"24","author":"Nordestgaard","year":"2025","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101574_bib0036","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of c-reactive protein across the full range of Framingham risk scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101574_bib0037","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1016\/j.ajpc.2026.101574_bib0038","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101574_bib0039","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ahj.2015.04.017","article-title":"Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality","volume":"170","author":"Parrinello","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajpc.2026.101574_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101320","article-title":"Clinical, economic, and health care resource utilization burden of acute myocardial infarction and the role of systemic inflammation in US hospitals: a real-world study","volume":"24","author":"Lv","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101574_bib0041","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.3390\/jcm13226744","article-title":"Comparison of outcomes between ST-segment elevation and non-ST-segment elevation myocardial infarctions based on left ventricular ejection fraction","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0042","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3349\/ymj.2021.62.5.400","article-title":"Higher long-term mortality in patients with non-ST-elevation myocardial infarction than ST-elevation myocardial infarction after discharge","volume":"62","author":"Han","year":"2021","journal-title":"Yonsei Med J"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101574_bib0043","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.biopha.2009.06.004","article-title":"Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models","volume":"63","author":"Di Stefano","year":"2009","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101574_bib0044","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1373\/clinchem.2007.087957","article-title":"Clinical application of c-reactive protein across the spectrum of acute coronary syndromes","volume":"53","author":"Scirica","year":"2007","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0045","first-page":"501","article-title":"C-reactive protein and its role in diagnosis, myocardial damage, and angiographic findings in patients with acute coronary syndrome","volume":"32","author":"Nadeem","year":"2025","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101574_bib0046","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2008.06.034","volume":"102","author":"Kuch","year":"2008","journal-title":"Am J Cardiol"},{"issue":"11_Supplement_1","key":"10.1016\/j.ajpc.2026.101574_bib0047","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0735-1097(20)30855-X","article-title":"Recurrent myocardial infarction after STEMI vs. NSTEMI","volume":"75","author":"Nair","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0048","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCOUTCOMES.115.002312","article-title":"Differences in short- and long-term outcomes among older patients with ST-elevation versus non-ST-elevation myocardial infarction with angiographically proven coronary artery disease","volume":"9","author":"Vora","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101574_bib0049","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ajpc.2026.101574_bib0050","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0051","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/ijms21030807","article-title":"Enhanced inflammation is a marker for risk of post-infarct ventricular dysfunction and heart failure","volume":"21","author":"\u015awi\u0105tkiewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2026.101574_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/250867","article-title":"Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction","volume":"2012","author":"Swiatkiewicz","year":"2012","journal-title":"Mediat Inflamm"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101574_bib0053","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101574_bib0054","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjmed.2006.07.039","article-title":"C-reactive protein and heart failure after myocardial infarction in the community","volume":"120","author":"Bursi","year":"2007","journal-title":"Am J Med"},{"issue":"25","key":"10.1016\/j.ajpc.2026.101574_bib0055","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","article-title":"The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes","volume":"114","author":"Dzau","year":"2006","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ajpc.2026.101574_bib0056","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.119.044282","article-title":"Secondary prevention for atherosclerotic cardiovascular disease","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101574_bib0057","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ahj.2018.07.014","article-title":"High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States","volume":"204","author":"Pagidipati","year":"2018","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.ajpc.2026.101574_bib0058","article-title":"Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of cardiology","volume":"S0735-1097","author":"Mensah","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0059","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jamainternmed.2022.0134","article-title":"Evaluating the association between low-density lipoprotein cholesterol reduction and relative and absolute effects of statin treatment: a systematic review and meta-analysis","volume":"182","author":"Byrne","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101574_bib0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamaneurol.2021.5578","article-title":"Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a meta-analysis of randomized clinical trials","volume":"79","author":"Lee","year":"2022","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0061","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/joim.13656","article-title":"Elevated low-density lipoprotein cholesterol: an inverse marker of morbidity and mortality in patients with myocardial infarction","volume":"294","author":"Schubert","year":"2023","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0062","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjcard.2014.12.006","article-title":"Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox)","volume":"115","author":"Reddy","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0063","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12916-024-03823-z","article-title":"The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med"},{"issue":"28","key":"10.1016\/j.ajpc.2026.101574_bib0064","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0065","first-page":"776","article-title":"Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Samuel","year":"2021","journal-title":"Can J Cardiol"},{"issue":"26","key":"10.1016\/j.ajpc.2026.101574_bib0066","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1016\/j.ajpc.2026.101574_bib0067","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","article-title":"Colchicine for secondary prevention of vascular events: a meta-analysis of trials","volume":"46","author":"d\u2019Entremont","year":"2025","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101574_bib0068","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease","volume":"82","author":"Nelson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101574_bib0069","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101574_bib0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","article-title":"Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic","volume":"76","author":"Bhatt","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0071","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13\u2009970 contemporary high-risk patients with statin intolerance","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101574_bib0072","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40620-024-02117-0","article-title":"Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?","volume":"38","author":"Kanbay","year":"2025","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101574_bib0073","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1681\/ASN.0000000000000245","article-title":"Effect of ziltivekimab on determinants of hemoglobin in patients with CKD stage 3-5: an analysis of a randomized trial (RESCUE)","volume":"35","author":"Pergola","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1016\/j.ajpc.2026.101574_bib0074","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101574_bib0075","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf108","article-title":"Targeting IL-6 in antibody-mediated kidney transplant rejection","volume":"18","author":"Kanbay","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ajpc.2026.101574_bib0076","series-title":"A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of pacibekitug subcutaneous quarterly or monthly in patients with elevated hs-CRP and chronic kidney disease: tranquility 90-day results","year":"2025"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:19:26Z","timestamp":1791587966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"alternative-id":["S2666667726001686"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101574","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of systemic inflammation with major adverse cardiovascular events in patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101574"}}